BioVie Inc. (BIVI) vs IRIDEX Corporation (IRIX)

A side-by-side comparison of BioVie Inc. and IRIDEX Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BIVI vs IRIX

growth of $100 · dividends reinvested · last 10y
BIVI -100.0% (-54.3%/yr)IRIX -95.2% (-26.2%/yr)IRIX compounded faster over this window
Log scale — wide-divergence pair
001101001kStart $10020182020202220242026$0$5
BIVI IRIX

BIVI vs IRIX: by the numbers

  • •IRIX is the larger company ($13M vs $11M market cap).
  • •Both run net losses; BIVI's is the smaller (0.00% vs -6.88% net margin).

Metrics side by side

Valuation

MetricBIVIIRIX
P/S ratioN/A0.24
P/B ratio1.08N/A

Profitability

MetricBIVIIRIX
Gross margin0.00%36.23%
Operating margin0.00%-5.39%
Net margin0.00%-6.88%
ROE-214.92%-97.47%
ROIC-216.67%-19.53%

Growth (annualized)

MetricBIVIIRIX
Revenue CAGR (5Y)N/A-0.57%
Total return CAGR (5Y)-70.37%-38.13%

Frequently asked

How have BIVI and IRIX total returns compared?
Over the past 10 years, BIVI delivered -54.09% and IRIX delivered -26.14% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.